Canada is reaching the limits of a drug policy centred on harm reduction — a philosophy that aims to limit the harms of substance use without insisting on abstinence. Despite the creation of over 40 supervised consumption sites, opioid overdose deaths have remained staggeringly high: more than 10,300 Canadians lost their lives to an opioid overdose between January 2016 and September 2018, the Public Health Agency of Canada recently reported. To read full article click here
“The results from the 2019 study show much promise that CBD’s has the potential to reduce cue-induced craving and anxiety and provides a strong basis for further investigation of cannabidiol as a treatment option for opioid use disorder.”
Study Source https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.18101191